1. Home
  2. BBIO vs WSO Comparison

BBIO vs WSO Comparison

Compare BBIO & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$74.63

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Logo Watsco Inc.

WSO

Watsco Inc.

HOLD

Current Price

$410.70

Market Cap

15.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBIO
WSO
Founded
2015
1945
Country
United States
United States
Employees
N/A
7050
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
15.3B
15.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BBIO
WSO
Price
$74.63
$410.70
Analyst Decision
Strong Buy
Hold
Analyst Count
25
6
Target Price
$86.04
$410.00
AVG Volume (30 Days)
1.5M
439.2K
Earning Date
04-28-2026
04-21-2026
Dividend Yield
N/A
3.27%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$502,076,000.00
N/A
Revenue This Year
$88.16
$3.12
Revenue Next Year
$74.13
$5.10
P/E Ratio
N/A
$34.24
Revenue Growth
126.26
N/A
52 Week Low
$31.77
$323.05
52 Week High
$84.94
$509.71

Technical Indicators

Market Signals
Indicator
BBIO
WSO
Relative Strength Index (RSI) 57.26 63.86
Support Level $70.65 $406.35
Resistance Level $78.20 $427.50
Average True Range (ATR) 2.54 16.55
MACD 0.48 5.92
Stochastic Oscillator 81.78 93.70

Price Performance

Historical Comparison
BBIO
WSO

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About WSO Watsco Inc.

Watsco is the largest HVAC and refrigeration products distributor in North America with approximately 13% market share. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada, Latin America, and the Caribbean. The company's customer base comprises more than 120,000 dealers and contractors serving the replacement and new-construction HVAC/R markets for residential and light-commercial applications. As much as 20% of residential HVAC units are distributed through Watsco in any given year. Revenue is approximately 75%-80% residential HVAC and 20%-25% commercial, with relatively small exposure to more complex "applied" solutions.

Share on Social Networks: